-
NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
21 Jan 2025 07:30 GMT
… non-small cell lung cancer receiving standard of care chemoradiation followed by consolidation … study in non-small cell lung cancer brings us another step closer …
-
ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Receptor and Activation of Nuclear Factor-Kappa B in Non-Small Cell Lung Cancer
20 Jan 2025 11:01 GMT
… metastatic cases, post chemoradiation, neoadjuvant chemotherapy and … BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, … -IIIA non-small-cell lung cancer (Impower010): a randomized, … of osimertinib tolerance in lung cancer. Lung Cancer. 2021;154:84– …
-
AstraZeneca Tagrisso approved in EU for patients with unresectable EGFR-mutated lung cancer
27 Dec 2024 09:45 GMT
… advanced, unresectable non-small cell lung cancer (NSCLC) whose tumours have … during or following platinum-based chemoradiation therapy (CRT).
The approval … historically experienced early progression after chemoradiation therapy. The powerful results …
-
AZ gets EU okay for Tagrisso in early-stage lung cancer
24 Dec 2024 13:08 GMT
… advanced, unresectable non-small cell lung cancer (NSCLC).
The European Commission has … during or following platinum-based chemoradiation therapy (CRT).
The highly … historically experienced early progression after chemoradiation therapy," he added.
…
-
AstraZeneca’s Tagrisso granted EC approval in EGFR-mutated lung cancer
23 Dec 2024 13:01 GMT
… advanced, unresectable non-small cell lung cancer (NSCLC) in adults whose tumours … -based chemoradiation therapy.
More than 450,000 people are diagnosed with lung cancer … EU for locally advanced, unresectable lung cancer, providing a new standard of …
-
AstraZeneca lung cancer drug Tagrisso approved by EU regulators
23 Dec 2024 10:33 GMT
… EGFR-mutated non-small cell lung cancer (NSCLC), after reducing the … ,000 people diagnosed with lung cancer in Europe each year, … for locally advanced, unresectable lung cancer, providing a new standard … early progression after chemoradiation therapy."
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… CT examination.
Discussion
Chemoradiation has been the … candidate drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis. … pathologic assessment of lung cancer resection specimens after …
-
Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic
29 Jan 2025 16:39 GMT
… will be second only to lung cancer in its lethality by 2025 … in the control group after chemoradiation.
CAN-2409 was also granted …
-
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
05 Dec 2024 12:23 GMT
… Notes
Small cell lung cancer
Lung cancer is the leading … for people with lung cancer, including and … lung-cancer-101/types-of-lung-cancer.
American Cancer Society. Small cell lung cancer … chemoradiation for patients with limited stage small cell lung cancer …
-
FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer
05 Dec 2024 01:10 GMT
… with limited-stage small cell lung cancer whose disease has not progressed … -durvalumab-limited-stage-small-cell-lung-cancer
Study of durvalumab + tremelimumab, … -cell lung cancer in patients who have not progressed following concurrent chemoradiation therapy …
About
© 1995-2025